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ABSTRACT 
Purpose This study was designed to find a reliable Epstein-Barr virus (EBV) immunoglobulin 
(Ig) G–based diagnostic/screening test for nasopharyngeal carcinoma (NPC) able to 
demarcate between the NPC-related seropositivity of EBV IgG antibodies and that of other 
head and neck cancer (HNCA) and control groups. The NPC-associated immunosuppression 
affects EBV IgA much more than IgG, leading to inconsistent detection of NPC using EBV 
IgA antibodies. Materials and methods One hundred twenty-two HNCA patients, 42 NPC, 66 
laryngeal carcinoma, and 14 hypopharyngeal carcinoma and 3 groups of 100 control subjects 
were enrolled in this study. Enzyme-linked immunosorbent assay (ELISA) was used to find a 
specific cutoff value for the NPC-related seropositivity of EBV IgG antibodies. Results NPC 
group showed higher serum level of EBV IgG antibodies than control and other HNCA 
groups (P < .05). However, the traditional cutoff value, mean + 2 SDs of control subjects, 
failed to demarcate the seropositives of NPC patients from those of healthy population (P > 
.05). The new cutoff value, mean + 2 SDs of the seropositives group of control subjects who 
had already been grouped by the traditional cutoff value, proved successful. It succeeded to 
demarcate between the NPC-related EBV IgG seropositivity and that issued from the 
persistent, latent, or reactivated EBV infection in the population (P < .05). The 
sensitivity/specificity of NPC detection by the new cutoff-based ELISA kit, 76.19% and 
86%, was close or higher than that of EBV IgA antibodies. Conclusion EBV IgG-based 
ELISA could be used for the diagnosis of NPC using a new cutoff threshold that excludes the 
population baseline of EBV IgG seropositivity.  
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